Is CVS Health Stock Outperforming the S&P 500?

Is CVS Health Stock Outperforming the S&P 500?

CVS Health Corporation (CVS) is a leading provider of health solutions, including healthcare and retail pharmacy services. With a market capitalization of $115.6 billion, the company offers prescription drugs, beauty, personal care, cosmetics and healthcare products, as well as pharmacy benefit management (PBM), disease management and administrative services. Companies worth $10 billion or more are…

Read More
Better Health Care ETF: Fidelity’s FHLC vs. State Street’s XLV

Better Health Care ETF: Fidelity’s FHLC vs. State Street’s XLV

Investors choose between Fidelity MSCI Healthcare Index ETF (NYSEMKT:FHLC) and State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) The former is likely to provide broader market cap exposure, while the latter offers superior liquidity and a higher trailing 12-month dividend yield. Both funds target the domestic healthcare sector and offer exposure to pharmaceutical, biotechnology…

Read More
Eli Lilly and Company (LLY) Gains as Medicare Expansion of GLP-1 Weight-Loss Drugs Eases Price Concerns

Eli Lilly and Company (LLY) Gains as Medicare Expansion of GLP-1 Weight-Loss Drugs Eases Price Concerns

Impax Asset Management’s “Impax US Sustainable Economy Fund” published its Q4 2025 investor letter. A copy of the letter can be downloaded here. The fund reported that equity markets remained volatile during the quarter amid concerns about elevated valuations and financing for large-scale data center investments, although the portfolio modestly outperformed the benchmark Russell 1000…

Read More
The healthcare sector is gaining momentum. Look at this stock chart for a reversal setup.

The healthcare sector is gaining momentum. Look at this stock chart for a reversal setup.

While most investors remain focused on mega-cap technology and index performance, a different story has been developing beneath the surface. In a recent Market at closing Live, Senior Market Strategist John Rowland, CMT, highlighted a signal that often precedes sector leadership: broad participation, improving momentum, and confirmation of both economic data and price action. That…

Read More
AI Startup WellTheory Raises M from General Catalyst, Accel and 7wire Ventures to Transform Autoimmune Health for Millions of Patients

AI Startup WellTheory Raises $14M from General Catalyst, Accel and 7wire Ventures to Transform Autoimmune Health for Millions of Patients

Benzinga and Yahoo Finance LLC may earn commissions or revenue on some articles through the links below. Well theoryA female-founded health tech startup that uses artificial intelligence to transform autoimmune care, announced Tuesday that it has secured $14 million in Series A funding. The round was led by General catalystwith the participation of 7wire companies,…

Read More